Global Information
회사소개 | 문의

세계의 미생물 검사 및 임상 미생물학 시장 예측(-2023년) : 호흡기질환, 혈류감염증, 소화기질환, 성감염증(STD), 요로감염증(UTI), 치주질환

Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User - Global Forecast to 2023

리서치사 MarketsandMarkets
발행일 2018년 06월 상품 코드 322916
페이지 정보 영문 224 Pages
가격
US $ 5,650 ₩ 6,446,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,586,900 PDF by E-mail (5-user license) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,298,300 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,409,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 미생물 검사 및 임상 미생물학 시장 예측(-2023년) : 호흡기질환, 혈류감염증, 소화기질환, 성감염증(STD), 요로감염증(UTI), 치주질환 Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User - Global Forecast to 2023
발행일: 2018년 06월 페이지 정보 : 영문 224 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계의 임상 미생물학 시장은 2018년 36억 5,000만 달러에서 2023년까지 49억 5,000만 달러에 이를 것으로 예측되며, 2018-2023년간 연평균 복합 성장률(CAGR)은 6.4%를 나타낼 전망입니다. 시장 성장을 촉진하는 주요인은 감염증 진단 분야에서의 지속적 기술 진보, 감염증 이환율 상승과 전염병 발생 증가, 연구와 혁신에 대한 자금·민관투자 증가입니다. 그러나, 의료비 상환 우려와 형편이 좋지 못한 규제 상황은 시장 성장을 어느 정도 억제하고 있습니다.

세계의 미생물 검사(Microbiology Testing) 및 임상 미생물학(Clinical Microbiology) 시장에 대해 조사 분석했으며, 용도·제품·질병 분야·최종사용자·지역별 동향, 시장 영향요인과 시장 기회, 경쟁 환경과 시장 점유율, 주요 사업자 개요 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

  • 미생물 검사 시장
  • 미생물 검사 시장 : 용도별
  • 임상 미생물학 시장
  • 임상 미생물학 제품 시장 : 지역별
  • 임상 미생물학 시장 : 질병 분야별
  • 임상 미생물학 시장 지역별 분석 : 최종사용자별

제5장 시장 개요

  • 서론
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제 요인
    • 시장 기회
    • 시장이 해결해야 할 과제

제6장 미생물 검사 시장 : 용도별

  • 서론
  • 의약품 용도
  • 임상 용도
  • 식품검사 용도
  • 에너지 용도
  • 화학제품 및 매트리얼 제조 용도
  • 환경 용도

제7장 임상 미생물학 시장 : 제품별

  • 서론
  • 기구
    • 실험실용 기구
    • 미생물 분석 장치
  • 시약
    • 병원균 전용 키트
    • 일반 시약

제8장 임상 미생물학 시장 : 질병 분야별

  • 서론
  • 호흡기질환
  • 혈류감염증
  • 소화기질환
  • 성감염증(STD)
  • 요로감염증(UTI)
  • 치주질환
  • 기타 질환

제9장 임상 미생물학 시장 : 최종사용자별

  • 서론
  • 병원 및 진단센터
  • 커스텀 실험실 서비스 프로바이더
  • 대학 및 연구기관

제10장 미생물 검사/임상 미생물학 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 기타 유럽(ROE)
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 기타 아시아태평양
  • 기타 지역(ROW)
    • 라틴아메리카
    • 중동 및 아프리카

제11장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 경쟁 구도

제12장 기업 개요(서론, 제품 및 서비스, 전략 & 애널리스트 고찰, 발전 동향, MNM의 견해)

  • BIOMERIEUX S.A.
  • DANAHER CORPORATION
  • BECTON, DICKINSON AND COMPANY
  • ABBOTT LABORATORIES, INC.
  • ROCHE DIAGNOSTICS(A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.)
  • BRUKER CORPORATION
  • HOLOGIC, INC.
  • BIO-RAD LABORATORIES INC.
  • QIAGEN
  • THERMO FISHER SCIENTIFIC
  • AGILENT
  • MERCK KGAA
  • Shimadzu
  • 3M
  • NEOGEN

제13장 부록

LSH 18.07.09

영문목차

"The global clinical microbiology market is projected to grow at a CAGR of 6.4% in the next five years"

The global clinical microbiology market is projected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4% from 2018 to 2023. Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation. However, factors such as reimbursement concerns and unfavorable regulatory scenario are restraining the growth of this market to a certain extent.

"The reagents segment is projected to grow at the highest CAGR during the forecast period."

By product, the clinical microbiology market is classified into instruments (laboratory instruments and microbiology analyzers) and reagents (pathogen-specific kits and general reagents). In 2018, the instruments product segment accounted for the largest share of the market, however, the reagents product segment is expected to grow at a higher rate during the forecast period. The growth of the reagents segment can be attributed to the high prevalence of infectious diseases across major markets, growing trend of reagent rental agreements along with instrument sales, and the increasing number of life science researches in the field of pathogen-specific reagents.

"Asia Pacific to witness the highest growth during the forecast period (2018-2023)"

North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period. Factors such as the growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence and prevalence of infectious diseases in the region.

Break-up of primary participants was as mentioned below:

  • By Company Type - Tier 1-33%, Tier 2-46% and Tier 3-21%
  • By Designation - C-level-26%, Director Level-20%, Others-54%
  • By Region - North America-33%, Europe-29%, Asia Pacific-24%, RoW-14%

Note: RoW includes Latin America and the Middle East & Africa

Some of the major market players in the microbiology testing/clinical microbiology market are: bioMerieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.

Research Coverage:

This report studies the microbiology testing market based on applications and region and the clinical microbiology market based on product, disease area, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and trends) which affect market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for key players. The microbiology testing/clinical microbiology market report profiles key players who are involved in the manufacturing and commercialization of microbiology testing products and analyzes their core competencies. The report also tracks and analyzes competitive developments in the market such as product launches and enhancements; acquisitions; partnerships and collaborations; and expansions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help players capture larger market shares. Firms purchasing the report could use any one or a combination of the below-mentioned strategies to strengthen their position in the market:

  • Market Penetration: Comprehensive information on the top 15 players in the microbiology testing/clinical microbiology market. The report analyzes the microbiology testing market by application and region; and the clinical microbiology market by product, disease area, end user, and region
  • Product Development/Innovation: Detailed insights on research and development activities and new product launches in the microbiology testing/clinical microbiology market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various microbiology testing products across five geographies (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa)
  • Competitive Assessment: Assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the clinical microbiology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY AND PRICING
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. OPPORTUNITY INDICATORS
    • 2.2.1. INTRODUCTION
    • 2.2.2. DEMAND-SIDE ANALYSIS
      • 2.2.2.1. Burden of infectious diseases
      • 2.2.2.2. Healthcare expenditure patterns
      • 2.2.2.3. Rapid growth in geriatric population
    • 2.2.3. SUPPLY-SIDE ANALYSIS
      • 2.2.3.1. The number of new products launched as clinical microbiology products
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. RESEARCH LIMITATIONS AND ASSUMPTIONS
    • 2.5.1. LIMITATIONS
    • 2.5.2. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MICROBIOLOGY TESTING MARKET (2018-2023)
  • 4.2. MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018-2023(USD BILLION)
  • 4.3. CLINICAL MICROBIOLOGY MARKET (2018-2023)
  • 4.4. CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2018)
  • 4.5. CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2018 VS. 2023(USD MILLION)
  • 4.6. GEOGRAPHIC ANALYSIS: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018 VS. 2023(USD MILLION)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Technological advancements in disease diagnostics
      • 5.2.1.2. Rising incidence of infectious diseases and growing outbreaks of epidemics
      • 5.2.1.3. Increased funding and public-private investments
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Limited reimbursement policies for microbiology testing procedures
      • 5.2.2.2. Unfavorable regulatory scenario
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Improving healthcare infrastructure across emerging countries
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Operational barriers related to the use of diagnostic tests
      • 5.2.4.2. Bundled sales of microbiology testing products - A key challenge for small and emerging reagent manufacturers

6. MICROBIOLOGY TESTING MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. PHARMACEUTICAL APPLICATIONS
  • 6.3. CLINICAL APPLICATIONS
  • 6.4. FOOD TESTING APPLICATIONS
  • 6.5. ENERGY APPLICATIONS
  • 6.6. CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS
  • 6.7. ENVIRONMENTAL APPLICATIONS

7. CLINICAL MICROBIOLOGY MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. INSTRUMENTS
    • 7.2.1. LABORATORY INSTRUMENTS
      • 7.2.1.1. Incubators
      • 7.2.1.2. Gram stainers
      • 7.2.1.3. Bacterial colony counters
      • 7.2.1.4. Autoclave sterilizers
      • 7.2.1.5. Microbial air samplers
      • 7.2.1.6. Anaerobic culture systems
      • 7.2.1.7. Petri dish fillers
      • 7.2.1.8. Blood culture systems
      • 7.2.1.9. Microbial culture systems
      • 7.2.1.10. Other laboratory instruments
    • 7.2.2. MICROBIOLOGY ANALYZERS
      • 7.2.2.1. Molecular diagnostic instruments
      • 7.2.2.2. Microscopes
      • 7.2.2.3. Mass spectrometers
  • 7.3. REAGENTS
    • 7.3.1. PATHOGEN-SPECIFIC KITS
    • 7.3.2. GENERAL REAGENTS

8. CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA

  • 8.1. INTRODUCTION
  • 8.2. RESPIRATORY DISEASES
  • 8.3. BLOODSTREAM INFECTIONS
  • 8.4. GASTROINTESTINAL DISEASES
  • 8.5. SEXUALLY TRANSMITTED DISEASES
  • 8.6. URINARY TRACT INFECTIONS
  • 8.7. PERIODONTAL DISEASES
  • 8.8. OTHER DISEASES

9. CLINICAL MICROBIOLOGY MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS & DIAGNOSTIC CENTERS
  • 9.3. CUSTOM LAB SERVICE PROVIDERS
  • 9.4. ACADEMIC & RESEARCH INSTITUTES

10. MICROBIOLOGY TESTING/CLINICAL MICROBIOLOGY MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. REST OF EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF APAC
  • 10.5. REST OF THE WORLD (ROW)
    • 10.5.1. LATIN AMERICA
    • 10.5.2. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SCENARIO
    • 11.3.1. KEY PRODUCT LAUNCHES AND APPROVALS (2014-2018)
    • 11.3.2. KEY AGREEMENT, PARTNERSHIPS, AND COLLABORATIONS (2014-2018)
    • 11.3.3. KEY ACQUISITIONS AND DIVESTMENTS (2014-2018)
    • 11.3.4. KEY EXPANSIONS (2014-2018)

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. BIOMERIEUX
  • 12.2. DANAHER CORPORATION
  • 12.3. BECTON, DICKINSON AND COMPANY
  • 12.4. ABBOTT
  • 12.5. ROCHE DIAGNOSTICS (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.)
  • 12.6. BRUKER
  • 12.7. HOLOGIC
  • 12.8. BIO-RAD
  • 12.9. QIAGEN
  • 12.10. THERMO FISHER SCIENTIFIC
  • 12.11. AGILENT
  • 12.12. MERCK KGAA
  • 12.13. SHIMADZU
  • 12.14. 3M
  • 12.15. NEOGEN

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 2: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 3: MICROBIOLOGY TESTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: MICROBIOLOGY TESTING MARKET FOR FOOD TESTING APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: MICROBIOLOGY TESTING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: MICROBIOLOGY TESTING MARKET FOR CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 9: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 10: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 12: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 14: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 15: CLINICAL MICROBIOLOGY INCUBATORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: CLINICAL MICROBIOLOGY GRAM STAINERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: CLINICAL MICROBIOLOGY BACTERIAL COLONY COUNTERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: CLINICAL MICROBIOLOGY AUTOCLAVE STERILIZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: CLINICAL MICROBIOLOGY MICROBIAL AIR SAMPLERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: CLINICAL MICROBIOLOGY ANAEROBIC CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: CLINICAL MICROBIOLOGY PETRI DISH FILLERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: CLINICAL MICROBIOLOGY BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: CLINICAL MICROBIOLOGY MICROBIAL CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: CLINICAL MICROBIOLOGY OTHER LABORATORY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 26: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 28: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 29: CLINICAL MICROBIOLOGY MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 30: CLINICAL MICROBIOLOGY MICROSCOPES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: CLINICAL MICROBIOLOGY MASS SPECTROMETERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 32: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 33: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 34: CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 36: CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 37: CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 38: CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 39: CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 40: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 41: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 42: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 43: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 44: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 45: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 46: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 47: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 48: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 49: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 50: CLINICAL MICROBIOLOGY MARKET FOR CUSTOM LAB SERVICE PROVIDERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 51: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 52: MICROBIOLOGY TESTING MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 53: CLINICAL MICROBIOLOGY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 54: NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 55: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 56: NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 57: NORTH AMERICA: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: NORTH AMERICA: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 59: NORTH AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 60: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 61: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 62: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 63: US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 64: US: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 65: US: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 67: CANADA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: CANADA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 69: EUROPE: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 70: EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 71: EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 72: EUROPE: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 73: EUROPE: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 74: EUROPE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 75: EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 76: EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 77: EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 78: GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 79: GERMANY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: GERMANY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 81: UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 82: UK: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: UK: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 84: FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 85: FRANCE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 86: FRANCE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 87: ROE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 88: ROE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 89: ROE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: APAC: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 91: APAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 92: APAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: APAC: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: APAC: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 95: APAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 96: APAC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 97: APAC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 98: APAC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 99: JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 100: JAPAN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: JAPAN: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 103: CHINA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 104: CHINA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 105: INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 106: INDIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 107: INDIA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: ROAPAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 109: ROAPAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 110: ROAPAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: ROW: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 112: ROW: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 113: ROW: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 114: ROW: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 115: ROW: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 116: ROW: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 117: ROW: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
  • TABLE 118: ROW: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 119: ROW: CLINICAL MICROBIOLOGY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 120: LATAM: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 121: LATAM: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: LATAM: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 123: MEA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 124: MEA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 125: MEA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: SOUTH AFRICA AND INDIA HAD THE LARGEST HIV-AIDS PATIENT POPULATION DURING 2010-2016
  • FIGURE 3: HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2005-2015
  • FIGURE 4: HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS, 2005-2015
  • FIGURE 5: INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011-2030)
  • FIGURE 6: PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION (1980-2010 VS. 2010-2040)
  • FIGURE 7: INCREASE IN THE PROPORTION OF GERIATRIC INDIVIDUALS IN THE OVERALL POPULATION, BY COUNTRY (2011-2030)
  • FIGURE 8: THE NUMBER OF NEW PRODUCTS LAUNCHED IN THE CLINICAL MICROBIOLOGY MARKET (2014-2017)
  • FIGURE 9: BOTTOM-UP APPROACH: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET
  • FIGURE 10: TOP-DOWN APPROACH: MICROBIOLOGY TESTING MARKET
  • FIGURE 11: DATA TRIANGULATION
  • FIGURE 12: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 13: CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2018)
  • FIGURE 14: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA (2018 VS. 2023)
  • FIGURE 15: CLINICAL MICROBIOLOGY MARKET SHARE, BY REGION (2018)
  • FIGURE 16: INCREASING GLOBAL BURDEN OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE MICROBIOLOGY TESTING INDUSTRY
  • FIGURE 17: PHARMACEUTICAL APPLICATIONS ARE EXPECTED TO DOMINATE THE MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: INCREASED FUNDING AND PUBLIC-PRIVATE INVESTMENT ARE KEY FACTORS DRIVING MARKET GROWTH
  • FIGURE 19: NORTH AMERICA IS EXPECTED TO DOMINATE THE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT
  • FIGURE 20: RESPIRATORY DISEASES ARE EXPECTED TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT IS EXPECTED TO DOMINATE THE CLINICAL MICROBIOLOGY MARKETS ACROSS ALL REGIONS UNTIL 2023
  • FIGURE 23: PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE - DEVELOPED VS. DEVELOPING COUNTRIES (2005-2015)
  • FIGURE 24: FOOD TESTING APPLICATIONS TO REGISTER THE HIGHEST GROWTH RATE IN THE GLOBAL MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: LABORATORY INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY INSTRUMENTS MARKET UNTIL 2023
  • FIGURE 26: INCUBATORS TO DOMINATE THE CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: MOLECULAR DIAGNOSTIC INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY ANALYZERS MARKET UNTIL 2023
  • FIGURE 28: PATHOGEN-SPECIFIC KITS ARE EXPECTED TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY REAGENTS MARKET
  • FIGURE 29: RESPIRATORY DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 30: CUSTOM LAB SERVICE PROVIDERS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 31: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
  • FIGURE 32: EUROPE: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
  • FIGURE 33: APAC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
  • FIGURE 34: ROW: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
  • FIGURE 35: KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CLINICAL MICROBIOLOGY MARKET, 2014-2017
  • FIGURE 36: GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2017
  • FIGURE 37: BIOMERIEUX: COMPANY SNAPSHOT
  • FIGURE 38: DANAHER: COMPANY SNAPSHOT
  • FIGURE 39: BD: COMPANY SNAPSHOT
  • FIGURE 40: ABBOTT: COMPANY SNAPSHOT
  • FIGURE 41: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • FIGURE 42: BRUKER: COMPANY SNAPSHOT
  • FIGURE 43: HOLOGIC: COMPANY SNAPSHOT
  • FIGURE 44: BIO-RAD: COMPANY SNAPSHOT
  • FIGURE 45: QIAGEN: COMPANY SNAPSHOT
  • FIGURE 46: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 47: AGILENT: COMPANY SNAPSHOT
  • FIGURE 48: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 49: SHIMADZU: COMPANY SNAPSHOT
  • FIGURE 50: 3M: COMPANY SNAPSHOT
  • FIGURE 51: NEOGEN: COMPANY SNAPSHOT
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research